Gene · 710
Papers4,575
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
921 to 940 of 4,575
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Advancing precision medicines for ocular disorders: Diagnostic genomics to tailored therapies. | Front Med (Lausanne) | 2022 | 35911417 | PubTator, text mining | PubMed |
| Using an extended treatment regimen of lanadelumab in the prophylaxis of hereditary angioedema: a single-centre experience. | World Allergy Organ J | 2022 | 35891672 | PubTator, text mining | PubMed |
| Network Proximity-Based Drug Repurposing Strategy for Early and Late Stages of Primary Biliary Cholangitis. | Biomedicines | 2022 | 35884999 | PubTator, text mining | PubMed |
| IDO1, FAT10, IFI6, and GILT Are Involved in the Antiretroviral Activity of γ-Interferon and IDO1 Restricts Retrovirus Infection by Autophagy Enhancement. | Cells | 2022 | 35883685 | PubTator, text mining | PubMed |
| Cancer-associated fibroblasts in the single-cell era. | Nat Cancer | 2022 | 35883004 | PubTator, text mining | PubMed |
| Transcriptomic and proteomic retinal pigment epithelium signatures of age-related macular degeneration. | Nat Commun | 2022 | 35882847 | PubTator, text mining | PubMed |
| Pathogenic Variants in Cardiomyopathy Disorder Genes Underlie Pediatric Myocarditis-Further Impact of Heterozygous Immune Disorder Gene Variants? | J Cardiovasc Dev Dis | 2022 | 35877578 | PubTator, text mining | PubMed |
| Added Value of Reanalysis of Whole Exome- and Whole Genome Sequencing Data From Patients Suspected of Primary Immune Deficiency Using an Extended Gene Panel and Structural Variation Calling. | Front Immunol | 2022 | 35874679 | PubTator, text mining | PubMed |
| A Novel Thrombosis-Related Signature for Predicting Survival and Drug Compounds in Glioblastoma. | J Oncol | 2022 | 35874629 | PubTator, text mining | PubMed |
| Validation of Serotransferrin in the Serum as Candidate Biomarkers for the Diagnosis of Pulmonary Tuberculosis by Label-Free LC/MS. | ACS Omega | 2022 | 35874208 | PubTator, text mining | PubMed |
| Searching for Genetic Biomarkers for Hereditary Angioedema Due to C1-Inhibitor Deficiency (C1-INH-HAE). | Front Allergy | 2022 | 35873600 | PubTator, text mining | PubMed |
| A large-scale polygenic risk score analysis identified candidate proteins associated with anxiety, depression and neuroticism. | Mol Brain | 2022 | 35870967 | PubTator, text mining | PubMed |
| Transforming growth factor-β signaling governs the differentiation program of extravillous trophoblasts in the developing human placenta. | Proc Natl Acad Sci U S A | 2022 | 35867736 | PubTator, text mining | PubMed |
| Prevalence and determinants of atrial fibrillation progression in paroxysmal atrial fibrillation. | Heart | 2022 | 35858774 | PubTator, text mining | PubMed |
| Effects of the complement system on antibody formation and function: implications for transplantation. | Curr Opin Organ Transplant | 2022 | 35857345 | PubTator, text mining | PubMed |
| Practical Management for Use of Eculizumab in the Treatment of Severe, Refractory, Non-Thymomatous, AChR + Generalized Myasthenia Gravis: A Systematic Review. | Ther Clin Risk Manag | 2022 | 35855752 | PubTator, text mining | PubMed |
| Omic Technologies in HIV: Searching Transcriptional Signatures Involved in Long-Term Non-Progressor and HIV Controller Phenotypes. | Front Immunol | 2022 | 35844607 | PubTator, text mining | PubMed |
| Key Factors for Thymic Function and Development. | Front Immunol | 2022 | 35844535 | PubTator, text mining | PubMed |
| Acute respiratory distress and amniotic fluid embolism in pregnancy. | Best Pract Res Clin Obstet Gynaecol | 2022 | 35840499 | PubTator, text mining | PubMed |
| Inhibition of the lectin pathway of complement ameliorates hypocomplementemia and restores serum bactericidal activity in patients with severe COVID-19. | Clin Transl Med | 2022 | 35839316 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/710/papers?page=47